Sharps Technology Reports 2025 Year-End Results and Highlights Continued Execution of Solana Treasury Strategy
Rhea-AI Summary
Sharps Technology (NASDAQ:STSS) reported 2025 year-end results highlighting a strategic shift to a Solana-based digital asset treasury. The company holds over 2 million SOL (≈95% staked at ~7% gross yield), reported $269.1M total assets (up from $7.3M), and raised over $430M in FY2025.
Revenue totaled ≈$7.0M (≈$6.8M staking revenue; $204k product revenue). Stockholders’ equity rose to $264.4M, liabilities fell to $4.7M, and legacy manufacturing was phased out to focus on staking, institutional partnerships, and capital deployment.
Positive
- Total assets increased to $269.1M from $7.3M year-end 2024
- Stockholders’ equity grew to $264.4M from $2.0M year-end 2024
- Accumulated over 2 million SOL with ~95% actively staked
- Raised over $430M in capital during FY2025
Negative
- FY2025 revenue of $7.0M was almost entirely staking-derived ($6.8M), with only $204k product revenue
- Balance sheet concentration: $250.1M in digital assets (~93% of total assets)
- Major capital raises via equity and warrant exercises may have dilution implications for shareholders
News Market Reaction – STSSW
On the day this news was published, STSSW gained 48.64%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
STSSW showed a sharp pre-news decline of 41.59% while peers were mixed: NXGLW (-1.47%), LUCYW (0%), MLSS (-5.86%), NEPH (-2.05%), RVP (-0.36%). Momentum scanner peers (MLSS, FEMY, NXGL) skewed up, highlighting stock-specific dynamics for STSSW rather than a sector-wide move.
Previous Crypto Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 05 | Crypto partnership | Positive | +1.9% | Collaboration with BitGo to institutionalize Solana treasury strategy. |
| Jan 26 | Staking income update | Positive | -2.0% | Reported ~7% gross APY and nearly all SOL staked with no debt. |
| Jan 12 | Validator launch | Positive | +3.1% | Launched Coinbase-operated institutional-grade Solana validator. |
| Sep 29 | Crypto.com partnership | Positive | -3.3% | Partnered with Crypto.com to manage >2M SOL and expand ecosystem. |
Crypto-related announcements have produced a mix of small gains and losses, with reactions roughly balanced between positive and negative moves.
Over recent crypto-tagged updates, Sharps has consistently advanced its Solana-focused treasury strategy—adding institutional partners like BitGo and Coinbase, reporting roughly 7% gross APY on staking, and expanding use of Solana validators. These events often emphasized security, custody, and yield optimization. Price reactions to these crypto updates have been modest and mixed, suggesting that while the market acknowledges the shift, it has not assigned uniformly positive or negative value to these developments ahead of this year-end report.
Historical Comparison
Prior crypto-focused announcements for Sharps produced an average move of -0.08%, indicating historically modest and mixed trading responses to Solana treasury news.
Crypto-tagged history shows progression from acquiring over 2 million SOL, to institutional partnerships (Crypto.com, Coinbase, BitGo), to reporting validator yields near 7%, culminating in this year-end framing of Solana assets as the core balance sheet driver.
Market Pulse Summary
The stock surged +48.6% in the session following this news. A strong positive reaction aligns with the article’s emphasis on a transformed balance sheet, with total assets of $269.1 million, stockholders’ equity of $264.4 million, and a large Solana treasury generating roughly $6.8 million in staking revenue. Historically, crypto-related news produced modest, mixed moves, so any large upside could outpace prior patterns and may remain sensitive to sentiment around Solana and equity capital raised in 2025.
Key Terms
staking technical
validator technical
digital assets financial
stablecoin financial
AI-generated analysis. Not financial advice.
- Over 2 Million SOL Held with Approximately
95% Staked at ~7% Gross Annualized Yield - Total Assets of
$269.1 Million , Up from$7.3 Million at Year-End 2024 - Expanded Solana Ecosystem Partnerships Including Coinbase, Crypto.com, BitGo, and Jupiter
NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (“Sharps” or the “Company”), a medical device sales and distribution company that has adopted a Solana-based digital asset treasury strategy, has announced financial results for the year ended December 31, 2025, and provided an update on the continued execution of its treasury and infrastructure strategy.
The Company entered 2025 as a capital-constrained medical device manufacturer and exited 2025 with what management believes is the strongest financial and strategic platform in the Company’s history. In a matter of months, Sharps launched a Solana-focused digital asset treasury strategy, accumulated more than 2 million SOL, established a recurring staking income stream with ~
“Our 2025 year-end results reflect a pivotal transition for Sharps Technology,” said Paul K. Danner, Executive Chairman. “During the year, we transformed the Company’s balance sheet, completed our strategic shift away from unprofitable legacy operating activities, established a treasury position of more than 2 million SOL, and laid the foundation for a more scalable and capital-efficient platform. As we move through 2026, we intend to build on a foundation that simply didn’t exist a year ago to grow the Company’s business.”
With legacy manufacturing activities being phased out and a sizable SOL treasury now in place, Sharps believes it is operating from a position of substantially greater strength than a year ago. The Company is focused on maximizing staking economics across its treasury, leveraging institutional-grade counterparties and infrastructure, and deploying its balance sheet in ways management believes can accelerate long-term value creation.
Key highlights from 2025 and recent developments:
- As of December 31, 2025, the Company held over 2 million SOL with approximately
95% actively staked. - The Company had total revenue of approximately
$7.0 million for FY 2025, including$6.8 million in net staking revenue, which represented an approximately7% gross annualized validator staking yield, and$204,120 in product revenue from medical device distribution. - The Company exited FY 2025 with total assets of
$269.1 million (up from$7.3 million at year-end 2024), including$250.1 million in digital assets at fair value,$10.4 million in cash, and positive working capital of$14.2 million . Stockholders’ equity grew to$264.4 million (from$2.0 million at year-end 2024), while total liabilities declined to$4.7 million . The notes payable balance of$3.8 million at year-end 2024 was fully eliminated. - The Company launched its Sharps-branded validator through Coinbase’s institutional infrastructure and expanded strategic partnerships across the Solana ecosystem, including collaborations with Crypto.com, BitGo, Jupiter Exchange, The Tie, Bonk, and Pudgy Penguins.
- The Company raised over
$430 million in total capital during FY 2025 through equity offerings and warrant exercises, including cash, digital asset, and stablecoin contributions, funding the Company’s rapid SOL accumulation and treasury buildout.
Sharps enters 2026 as a materially reshaped company with a strengthened balance sheet, a productive digital asset treasury, a leaner operating profile, and expanded institutional relevance within the Solana ecosystem. Management believes the Company is now positioned not only to benefit from effective treasury execution, but also to leverage that foundation in support of broader strategic initiatives intended to enhance the Company’s long-term growth profile and open additional opportunities for future revenue generation. The Company’s focus in 2026 is to convert its stronger platform into sustained yield generation, disciplined capital deployment, and the measured development of collaborative business capabilities that can support its next stage of growth.
For more detailed information, please refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission on March 31, 2026.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements in this release other than statements of historical fact are forward-looking statements, including statements regarding the Company's execution of its Solana digital asset treasury strategy and the potential opportunities such initiatives may create for retail and institutional audiences. Forward-looking statements are based on current expectations, assumptions, and beliefs, and involve risks and uncertainties that could cause actual results to differ materially.
These risks and uncertainties include, among others: the Company's ability to successfully execute its Solana treasury strategy; volatility in the market price of SOL and other digital assets; changes in the regulatory or legal environments; competitive pressures; and general market, economic, and business conditions. Additional risks are described in the "Risk Factors" section of the Company's filings with the U.S. Securities and Exchange Commission (the "SEC"), which are available on the SEC's website at www.sec.gov.
Forward-looking statements speak only as of the date of this press release. The Company undertakes no obligation to update or revise these statements, whether as a result of new information, future developments, or otherwise, except as required by law.
About Sharps Technology
Sharps Technology is a medical device sales and distribution company that has adopted a digital asset treasury strategy focused on SOL, the native digital asset of the Solana blockchain. The Company is growing the Solana ecosystem through staking, validator infrastructure, and strategic collaborations. For additional information, please visit the Company’s website.
Contact
Sharps Technology IR
ir@sharpstechnology.com
